Effectiveness of Cannabinoids on Appetite in Scleroderma
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The cannabinoid has benefits in many aspects but the evidence of the effect of cannabinoids
in humans with SSc is limited. We, therefore, would like to investigate the efficacy of
cannabinoids on the appetite, sleep efficiency, quality of life, pain, and critical cytokine
level in SSc compared with placebo in SSc patients and the adverse events associated with
cannabinoids in those patients.